• Image of CALQUENCE medication Image of CALQUENCE medication
    • CALQUENCE

    • QTY 60
    • 100 MG
    • Tablet
    • Near  77381

ACALABRUTINIB (a KAL a BROO ti nib) treats leukemia and lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.


CALQUENCE Lifestyle Interactions

  • Acalabrutinib 100mg, Oral tablet

    Interaction: Grapefruit juice
    Severity: Major
    Notes for Consumers: Do not take eat or drink grapefruit/grapefruit juice while taking acalabrutinib without approval from your prescriber. Grapefruit juice may increase side effects from Acalabrutinib including fever or chills, cough, sore throat, pain or trouble passing urine, unusual bleeding or bruising, chest pain, dizziness, fast or irregular heartbeat, palpitations, feeling faint or lightheaded, or breathing problems.
    Notes for Professionals: Avoid the concomitant use of acalabrutinib and grapefruit juice; significantly increased acalabrutinib exposure may occur. Acalabrutinib is a CYP3A4 substrate; grapefruit juice is a strong CYP3A4 inhibitor. In healthy subjects, the Cmax and AUC values of acalabrutinib were increased by 3.9-fold and 5.1-fold, respectively, when acalabrutinib was coadministered with another strong inhibitor for 5 days.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.